Products for Research Use Only
RegisterLogin

HL22

CAT: 0931-T204148-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T204148-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Bioactivity
HL22 is a derivative of harmine. It exhibits significant inhibitory effects on three cancer cell lines: HCT116, MGC803, and MCF7. Moreover, HL22 can impede the migration and colony formation of MGC803 cells. Its anticancer mechanism is associated with multiple metabolic pathways and can be utilized for tumor research.
Smiles
CC1=NCCC2=C1N(C3=C2C=CC(=C3)OC)CCCCCN4C5=C(C=CC(=C5)OC)C6=C4C(=NC=C6)C
Molecular Formula
C31H34N4O2
Molecular Weight
494.627
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T79407-01HL23
TP3102-01HL2-m5

Alternative Products

CatalogName
HY-172097HL22
MBS488272-01Anti-CD22 [hL22 (Epratuzumab)]
GTR17858699Anti-CD22 [hL22 (Epratuzumab) ]
OAAV00872-200UGCD22 Recombinant Antibody [hL22 (Epratuzumab) ] (OAAV00409)
OAAV00873-200UGCD22 Recombinant Antibody [hL22 (Epratuzumab) ] (OAAV00410)
ENZ-ABS619-0200CD22 Recombinant monoclonal antibody (hL22) (Human IgG1κ)
ENZ-ABS620-0200CD22 Recombinant monoclonal antibody (hL22) (Rabbit IgGκ)
NBP3-13648Rabbit Monoclonal AIF-1/Iba1 Antibody (HL22)
MBS567078-01CD22 Recombinant monoclonal antibody (hL22) (Rabbit IgG kappa)
TA386080CD22 Human Monoclonal Antibody [Clone ID: hL22 (Epratuzumab)]

Popular Products